Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Anybody in NYC next week?




https://www.michaeljfox.org/research/parkinsons-therapeutics-conference.html?navid=pd-therapeutics-conf

The Parkinson's Disease Therapeutics Conference is The Michael J. Fox Foundation's annual scientific conference and the only one in the world focused exclusively on Parkinson's disease drug development. The 12th Annual PD Therapeutics Conference will be held on October 25, 2018 at Convene Midtown East, New York City.

We are delighted to have Carole Ho, MD chair our 2018 event.

The PD Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through speaker presentations and a poster session. The event is a platform for field leaders to share new and unpublished results and for fostering new relationships and collaborations.

2018 Posters


Nicolas Dzamko, PhD
The University of Sydney

Gert Geurtsen, PhD, MSc
Academic Medical Hospital of the University of Amsterdam

Martin Gill, PhD
Neuropore

Sarah Hamm-Alvarez, PhD
University of Southern California

Joohi Jiminez-Shahed, MD
Baylor College of Medicine

Robert Mach, PhD
University of Pennsylvania

Gary Miller, PhD
Emory University

Nicole Polinski, PhD
The Michael J. Fox Foundation

Shalini Padmanabhan, PhD
The Michael J. Fox Foundation

Tanya Simuni, MD
Northwestern University

Caryl Sortwell, PhD
Weston Brain Institute

Tanya Simuni, MD, directs the Northwestern University Feinberg School of Medicine’s Movement Disorders Center. She is the principal investigator on many Parkinson’s disease clinical trials and an expert on the design and coordination of multicenter studies. Dr. Simuni is leading a Phase III clinical trial evaluating isradipine as a potential disease-modifying agent in early Parkinson’s, which is supported by the National Institutes of Health.